Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 207.5M
Gross Profit 132.1M 63.64%
Operating Income -209.3M -100.85%
Net Income -187.1M -90.16%
EPS (Diluted) -$2.57

Balance Sheet Metrics

Total Assets 823.2M
Total Liabilities 401.8M
Shareholders Equity 421.4M
Debt to Equity 0.95

Cash Flow Metrics

Operating Cash Flow -149.0M
Free Cash Flow -164.7M

Revenue & Profitability Trend

Schrodinger Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue207.5M216.7M181.0M137.9M108.1M
Cost of Goods Sold75.5M76.0M79.9M72.3M44.6M
Gross Profit132.1M140.7M101.0M65.6M63.5M
Operating Expenses341.4M318.1M247.8M177.1M124.4M
Operating Income-209.3M-177.4M-146.8M-111.4M-60.9M
Pre-tax Income-185.7M42.9M-149.1M-100.8M-26.3M
Income Tax1.4M2.2M63.0K411.0K345.0K
Net Income-187.1M40.7M-149.2M-101.2M-26.6M
EPS (Diluted)-$2.57$0.54-$2.10-$1.42-$0.41

Income Statement Trend

Schrodinger Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets635.0M567.8M534.0M625.1M683.0M
Non-Current Assets188.2M235.2M154.6M131.4M63.3M
Total Assets823.2M803.0M688.6M756.5M746.3M
Liabilities
Current Liabilities191.7M133.7M108.8M91.2M73.2M
Non-Current Liabilities210.0M120.7M131.9M108.2M49.0M
Total Liabilities401.8M254.4M240.7M199.4M122.2M
Equity
Total Shareholders Equity421.4M548.6M447.9M557.1M624.0M

Balance Sheet Composition

Schrodinger Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-187.1M40.7M-149.2M-101.2M-26.6M
Operating Cash Flow-149.0M67.2M-124.7M-75.2M44.9M
Investing Activities
Capital Expenditures-7.3M-13.4M-8.0M-7.2M-2.5M
Investing Cash Flow148.8M45.8M78.2M-17.2M-386.3M
Financing Activities
Dividends Paid-----
Financing Cash Flow8.6M-392.0K025.0K537.1M
Free Cash Flow-164.7M-150.1M-127.7M-77.8M14.2M

Cash Flow Trend

Schrodinger Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 44.39
Forward P/E -8.35
Price to Book 4.05
Price to Sales 6.56
PEG Ratio -8.35

Profitability Ratios

Profit Margin -83.39%
Operating Margin -85.45%
Return on Equity -43.33%
Return on Assets -16.27%

Financial Health

Current Ratio 3.45
Debt to Equity 31.15
Beta 1.62

Per Share Data

EPS (TTM) -$2.63
Book Value per Share $5.09
Revenue per Share $3.16

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
sdgr1.5B44.394.05-43.33%-83.39%31.15
Veeva Systems 46.0B59.927.3914.06%27.34%1.24
Ge Healthcare 32.6B14.953.5526.44%11.03%97.52
Premier 1.9B21.461.186.85%4.96%19.35
Certara 1.7B104.001.56-0.25%-0.67%28.51
Omnicell 1.3B61.671.061.73%1.87%30.69

Financial data is updated regularly. All figures are in the company's reporting currency.